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Colorectal cancer (CRC) represents the second most 
common cancer worldwide and the third leading cause 
of cancer death. Most CRCs arise from premalignant 
colorectal lesions (mainly adenomas) that require years to 
develop an invasive disease. Early stage detection through 
the use of screening programs can sharply reduce CRC 
incidence and mortality allowing for better outcomes of 
the disease. The effectiveness of these programs may be 
strongly enhanced by targeting screening to individuals at 
higher risk. 
CRC is a multifactorial disease resulting from 
complex interactions between environmental and genetic 
factors. A great progress in understanding the underlying 
genetic factors of CRC has been made in the past two 
decades. Since the first genome-wide association study 
(GWAS) on CRC risk published in 2007 by Tomlinson 
et al. [1], more than 80 common single nucleotide 
polymorphisms (SNPs) in low-penetrance genes have been 
identified, with the majority of GWAS been conducted 
among European ancestry populations. It has been found 
that many of these risk variants lie in loci nowhere near 
known coding or regulatory regions, opening new exciting 
doors to mechanisms and pathways not previously known. 
Unlike the numerous studies performed in CRC, the 
relevance of genetic susceptibility in the development of 
premalignant colorectal lesions has been less evaluated. 
Colonic adenomas probably represent an intermediate 
phenotype between asymptomatic individuals carrying 
risk variants and CRC. A deeper knowledge of genetic 
factors related to premalignant lesions risk can also 
provide insight into the biological and genetic mechanisms 
relevant to initiation and progression of CRC. A recent 
study by Gargallo et al. [2] showed that several SNPs 
associated with CRC risk in previous GWAS (rs10505477, 
rs6983267, rs10795668, and rs11255841), are also 
involved in the susceptibility to colorectal adenomas or 
specific high- and low-risk adenoma subtypes. Of interest, 
the authors found these associations to be modified by the 
presence of family history of CRC. The low penetrance of 
most identified genetic variants associated with CRC does 
not provide clinically relevant information on their own, 
but combination of risk-associated alleles in a polygenic 
model has been reported to increase the risk of CRC in an 
additive or exponential way. 
Nowadays CRC screening guidelines are based 
mainly on age and family history. However, the elaboration 
of prediction risk models including environmental and 
genetic risk factors may allow a more accurate selection 
of low-and high-risk patients. Improving risk stratification 
will optimize the use of invasive technology and increase 
adherence to screening programs. The first risk prediction 
models for CRC were performed based on family history, 
lifestyle factors, and environmental risk factors. However, 
recent studies showed an increasing interest in developing 
genetic risk scores (GRS), combining common genetic 
variants associated with CRC for a more personalised 
risk assessment. In this context, Dunlop et al. [3], Yarnall 
et al. [4], and Jung et al. [5] developed prediction models 
that accounted lifestyle, environmental, and genetic 
factors, reporting a discriminatory accuracy using the area 
under the curve (AUC) with values ranging from 0.59 
to 0.74. Hsu et al. [6] developed sex- and site-specific 
models based on family history data and 27 SNPs adjusted 
for endoscopy history. They observed that adding the GRS 
to prediction models increased discriminatory accuracy 
from 0.51 to 0.59 (P = 0.0028) in men and from 0.52 to 
0.56 (P = 0.14) in women, compared to risk models based 
only on family history. Subsequent studies show similar 
results. Ibáñez-Sanz et al. reported a discriminatory 
accuracy value of 0.63 for CRC risk prediction model 
combining some modifiable risk factors (alcohol, obesity, 
physical activity, red meat and vegetable consumption, 
and nonsteroidal anti-inflammatory drug use), family 
history of CRC, and a GRS based on 21 susceptibility 
SNPs [7]. More recently, Weigl et al. [8] derived a GRS 
based only in a significant number of common variants 
(48 SNPs) previously associated with CRC. They 
observed that participants in the upper tertile of the GRS 
had a 2.7-fold increase in risk of advanced neoplasms 
(advanced adenomas and CRC) compared to those in the 
lower tertile. An increasing number of SNPs associated 
with CRC risk (63 SNPs, G-score) was evaluated by Jeon 
et al. [9] along with family history data and 19 life-
style and environmental factors (E-score). The model 
combining all scores estimated CRC risk with a 
discriminatory accuracy value of 0.63 for men and 0.62 
for women, higher in both genders when comparing to 
those models based only in family history or E-score and 
G-score separately. In line with these results, Balavarca 
et al. [10] after evaluate environmental factors and 
GRS for advanced colorectal neoplasm, they reported 
higher prediction values (AUC = 0.63) in the combined 
environmental-genetic score model compared with single 
environmental score (AUC = 0.584, p = 0.0002).  
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All these studies support the idea that adding 
genetic, environmental and lifestyle information into a 
CRC risk prediction model may significantly increase the 
discriminatory accuracy over models using only age and 
family history. Risk stratification could still be improved 
by integrating new discovered susceptibility SNPs to GRS 
as well as other relevant biomarkers such as epigenetic 
markers. Combining environmental, lifestyle factors and 
GRS in risk prediction models can help to tailor CRC 
prevention measures by adapting the onset age, nature and 
the intensity of CRC screening strategies. 
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